A highly efficient asymmetric synthesis of TRPV1 antagonistABT-102 was developed and successfully demonstrated on amulti-kilogram scale. This process incorporates a new asymmetric synthesis of (R)-tert-butylaminoindan, which is based ona chiral auxiliary induced diastereoselective reduction of itsiminoindan precursor.